Company intelligence / Profile preview

ImmunoDX

Woburn, Massachusetts, United States

Ownership: Private
Employees: ~1
Development stage: Other

Overview

ImmunoDX supplies specialty biologicals for research use, including recombinant proteins and antibodies utilized worldwide in diagnostics and assay development for infectious disease and cancer research. Clinical development results are not relevant as these products are for research use only and not clinical therapeutics.

Therapeutic areas: OncologyInfectious DiseasesRheumatology
Modalities: Recombinant proteinMonoclonal antibodyPolyclonal antibodyBiologic
Industry: Chemicals & Materials

Beyond the preview

Go deeper on ImmunoDX.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ImmunoDX.

Explore the full profile